These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates. Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE Elife; 2022 Feb; 11():. PubMed ID: 35103596 [TBL] [Abstract][Full Text] [Related]
3. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Tutterrow YL; Avril M; Singh K; Long CA; Leke RJ; Sama G; Salanti A; Smith JD; Leke RG; Taylor DW Infect Immun; 2012 Apr; 80(4):1479-90. PubMed ID: 22331427 [TBL] [Abstract][Full Text] [Related]
4. Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine. Gill J; Chakraborti S; Bharti P; Sharma A Int J Infect Dis; 2021 Nov; 112():35-39. PubMed ID: 34450283 [TBL] [Abstract][Full Text] [Related]
5. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design. Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695 [TBL] [Abstract][Full Text] [Related]
8. Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria. Fried M; Avril M; Chaturvedi R; Fernandez P; Lograsso J; Narum D; Nielsen MA; Oleinikov AV; Resende M; Salanti A; Saveria T; Williamson K; Dicko A; Scherf A; Smith JD; Theander TG; Duffy PE Infect Immun; 2013 Feb; 81(2):487-95. PubMed ID: 23208604 [TBL] [Abstract][Full Text] [Related]
9. Association of Antibodies to VAR2CSA and Merozoite Antigens with Pregnancy Outcomes in Women Living in Yaoundé, Cameroon. Lloyd YM; Fang R; Bobbili N; Vanda K; Ngati E; Sanchez-Quintero MJ; Salanti A; Chen JJ; Leke RGF; Taylor DW Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986889 [No Abstract] [Full Text] [Related]
10. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site. Babakhanyan A; Leke RG; Salanti A; Bobbili N; Gwanmesia P; Leke RJ; Quakyi IA; Chen JJ; Taylor DW PLoS One; 2014; 9(2):e88173. PubMed ID: 24505415 [TBL] [Abstract][Full Text] [Related]
11. Reduced risk of placental parasitemia associated with complement fixation on Plasmodium falciparum by antibodies among pregnant women. Opi DH; Boyle MJ; McLean ARD; Reiling L; Chan JA; Stanisic DI; Ura A; Mueller I; Fowkes FJI; Rogerson SJ; Beeson JG BMC Med; 2021 Aug; 19(1):201. PubMed ID: 34425801 [TBL] [Abstract][Full Text] [Related]
12. Designing a VAR2CSA-based vaccine to prevent placental malaria. Fried M; Duffy PE Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717 [TBL] [Abstract][Full Text] [Related]
13. High Antibodies to VAR2CSA in Response to Malaria Infection Are Associated With Improved Birthweight in a Longitudinal Study of Pregnant Women. McLean ARD; Opi DH; Stanisic DI; Cutts JC; Feng G; Ura A; Mueller I; Rogerson SJ; Beeson JG; Fowkes FJI Front Immunol; 2021; 12():644563. PubMed ID: 34220804 [TBL] [Abstract][Full Text] [Related]
14. Progress and Insights Toward an Effective Placental Malaria Vaccine. Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; Nielsen MA Front Immunol; 2021; 12():634508. PubMed ID: 33717176 [TBL] [Abstract][Full Text] [Related]
15. Cytoadhesion of Plasmodium falciparum-infected erythrocytes and the infected placenta: a two-way pathway. Costa FT; Avril M; Nogueira PA; Gysin J Braz J Med Biol Res; 2006 Dec; 39(12):1525-36. PubMed ID: 17160261 [TBL] [Abstract][Full Text] [Related]
16. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy. de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035 [TBL] [Abstract][Full Text] [Related]
17. Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women. Taylor DW; Zhou A; Marsillio LE; Thuita LW; Leke EB; Branch O; Gowda DC; Long C; Leke RF Infect Immun; 2004 Mar; 72(3):1603-7. PubMed ID: 14977967 [TBL] [Abstract][Full Text] [Related]
19. The Development, Fine Specificity, and Importance of High-Avidity Antibodies to VAR2CSA in Pregnant Cameroonian Women Living in Yaoundé, an Urban City. Vanda K; Bobbili N; Matsunaga M; Chen JJ; Salanti A; Leke RFG; Taylor DW Front Immunol; 2021; 12():610108. PubMed ID: 33717094 [TBL] [Abstract][Full Text] [Related]